WO2025212994 - ASSOCIATED FORMS OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS AND LOCAL ANESTHETICS
National phase entry is expected:
Publication Number
WO/2025/212994
Publication Date
09.10.2025
International Application No.
PCT/US2025/023114
International Filing Date
04.04.2025
Title **
[English]
ASSOCIATED FORMS OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS AND LOCAL ANESTHETICS
[French]
FORMES ASSOCIÉES DE MÉDICAMENTS ANTI-INFLAMMATOIRES NON STÉROÏDIENS ET ANESTHÉSIQUES LOCAUX
Applicants **
INNOVATOR THERAPEUTICS, LLC
Inventors
STAGNER, William, C.
DESHPANDAY, Ninad
OAKLEY, David, M.
CARDINAL, John, R.
Priority Data
63/574,659
04.04.2024
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
USPTO
* |
| * | |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2606 | |
| EPO | Filing, Examination, Granting | 16949 | |
| Japan | Filing, Examination, Granting | 2452 | |
| South Korea | Filing, Examination, Granting | 2607 | |
| USA | Filing, Examination, Granting | 4910 |
Total:
29,524
Abstract[English]
The present disclosure provides novel associated form (AF) of ketoprofen/dexketoprofen and lidocaine, and topical compositions thereof for use in topical products to treat patients with localized pain and inflammation. The novel ketoprofen/dexketoprofen and lidocaine AF acts as an extended-release drug delivery system due to extended release of the two drugs from the AF.[French]
La présente divulgation concerne une nouvelle forme associée (AF) de kétoprofène/dexkétoprofène et de lidocaïne, et des compositions topiques associées destinées à être utilisées dans des produits topiques pour traiter des patients présentant une douleur et une inflammation localisées. La nouvelle forme associée de kétoprofène/dexkétoprofène et de lidocaïne agit en tant que système d'administration de médicament à libération prolongée en raison d'une libération prolongée des deux médicaments à partir de la forme associée.